Quest Diagnostics Incorporated
Quest Diagnostics is a U.S.-based clinical laboratory company that provides diagnostic testing, pathology, and related information services through a nationwide network of laboratories and patient service centers. It also operates diagnostic solutions businesses that serve insurers and healthcare organizations with risk assessment and healthcare IT services.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueCore clinical lab testing, pathology, and diagnostic insights delivered to healthcare providers and patients.
Testing and analytics services used by insurers to support underwriting and risk evaluation.
Connectivity and information technology tools for providers and payers, including workflow and data services.
Customers
Quest sells primarily into the healthcare ecosystem, with physicians, hospitals, and patients/consumers as its main customer channels. It also serves health plans, employers, government agencies, pharmaceutical companies, retail healthcare providers, and other laboratories that use its testing, logistics, or data services.
Order routine and specialty diagnostic tests for patient diagnosis, treatment, and follow-up.
Buy outsourced laboratory and pathology services to extend capacity and access specialized testing.
Use Quest's network for direct access, convenience testing, and specimen collection services.
Use risk assessment and diagnostic services to support utilization, underwriting, and care management.
Buy testing, screening, and data-enabled services for workforce, research, and public health needs.
Strategy
Quest's strategy centers on expanding testing breadth, improving access, and using its scale and data assets to support better clinical decisions. It also emphasizes operational productivity through automation, AI, and process improvement across the lab, logistics, patient services, and revenue cycle.
A wider test menu increases relevance with physicians, hospitals, and consumers and supports cross-selling.
Convenient specimen collection and broad network coverage help capture more test volume as care shifts outside hospitals.
Diagnostic data can improve population health workflows and support value-based care relationships.
Laboratory testing is operationally intensive, so efficiency gains can improve competitiveness and service consistency.
Geography
Quest's business is centered in the United States, where it operates its headquarters, laboratories, patient service centers, and offices. It also maintains selected locations outside the United States, but the company’s operating footprint and customer base are overwhelmingly U.S.-oriented.
Risks
Quest faces regulatory, reimbursement, and operational risks typical of large clinical laboratory businesses, including changes in healthcare market structure and payer behavior. Its exposure also includes data privacy, integration risk from acquisitions, and legal or compliance issues tied to testing, billing, and healthcare information services.
- Healthcare market and reimbursement changesImpact: HighLikelihood: High
Quest depends on payer mix, fee schedules, and test utilization, so pricing and volume can be affected by policy and payer actions.
Exposure: Clinical laboratory testing and diagnostic services
- Regulatory and compliance riskImpact: HighLikelihood: Medium
Clinical labs operate under complex federal and state rules, including CLIA, billing, and medical practice requirements.
Exposure - Data privacy and cybersecurityImpact: HighLikelihood: Medium
The company handles sensitive patient and health information and uses large data assets in its services.
Exposure - Shifts in healthcare delivery and consumer behaviorImpact: MediumLikelihood: Medium
More care in retail, telemedicine, and home settings changes how specimens are collected and how customers access testing.
Exposure: Patient access network and mobile phlebotomy
- Acquisition integration and executionImpact: MediumLikelihood: Low
Quest uses acquisitions to expand capabilities, but integration can create cost, operational, and service risks.
Exposure: Clinical testing assets and specialty businesses
Accounting
Judgemental itemsReported revenue trends depend on volume, test mix, payer mix, and acquisition mix, so period-to-period comparability can be noisy.
Impact: Affects top-line growth interpretation and organic performance analysis
Recent acquisitions increase amortization expense and can pressure reported earnings without affecting cash flow directly.
Impact: Impacts operating income and net income
Fair value changes in acquisition-related earnouts can create non-cash gains or losses in other operating expense.
Impact: Can add volatility to operating results
Long-lived asset impairments and business exits can create one-time charges when assets are underutilized or discontinued.
Impact: Affects operating expense and comparability
Program-related separation and integration charges can be cash-consuming and recur over multiple periods.
Impact: Distorts underlying operating margin trends
Similar listed companies
Publicly listed companies with a comparable business focus.
Quest Patent Research Corp
QPRC · Wholesale-Miscellaneous Nondurable Goods
Quest Water Global, Inc.
QWTR · Air-Cond & Warm Air Heatg Equip & Comm & Indl Refrig Equip
QuidelOrtho Corp
QDEL · In Vitro & In Vivo Diagnostic Substances
QuidelOrtho Corp develops and markets diagnostic testing products used to detect, monitor, and help manage disease across clinical and decentralized care settings.
Qiagen N.V
QGEN · Biological Products, (No Diagnostic Substances)
Qwest Corp
CTHH · Telephone Communications (No Radiotelephone)
Qwest Corp is a U.S.-based telecommunications company that provides digital networking services over a large communications network.
Fulgent Genetics, Inc.
FLGT · Services-Medical Laboratories
Last updated: 24/09/2026